Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Common Equity (2016 - 2025)

Nutex Health's Common Equity history spans 16 years, with the latest figure at $423.4 million for Q4 2025.

  • For Q4 2025, Common Equity rose 124.6% year-over-year to $423.4 million; the TTM value through Dec 2025 reached $423.4 million, up 124.6%, while the annual FY2025 figure was $423.4 million, 124.6% up from the prior year.
  • Common Equity for Q4 2025 was $423.4 million at Nutex Health, down from $438.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $556.1 million in Q2 2022 and bottomed at $79.1 million in Q4 2023.
  • The 5-year median for Common Equity is $162.4 million (2021), against an average of $200.6 million.
  • The largest annual shift saw Common Equity skyrocketed 10278.91% in 2021 before it crashed 80.54% in 2023.
  • A 5-year view of Common Equity shows it stood at $191.6 million in 2021, then plummeted by 37.19% to $120.3 million in 2022, then tumbled by 34.26% to $79.1 million in 2023, then surged by 138.33% to $188.5 million in 2024, then surged by 124.6% to $423.4 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Common Equity are $423.4 million (Q4 2025), $438.0 million (Q3 2025), and $336.9 million (Q2 2025).